Tudor Investment Corp’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4M Buy
+40,217
New +$5.25M 0.01% 1315
2025
Q4
Sell
-4,138
Closed -$519K 4055
2025
Q3
$464K Sell
4,138
-119,578
-97% -$14M ﹤0.01% 2742
2025
Q2
$16.6M Buy
123,716
+18,890
+18% +$2.07M 0.04% 411
2025
Q1
$7.05M Buy
+104,826
New +$7.21M 0.02% 631
2024
Q3
Sell
-11,303
Closed -$1.74M 3109
2024
Q2
$1.7M Buy
11,303
+4,552
+67% +$546K 0.01% 1169
2024
Q1
$499K Sell
6,751
-80,190
-92% -$6.61M ﹤0.01% 1648
2023
Q4
$6.86M Buy
86,941
+48,110
+124% +$2.9M 0.06% 486
2023
Q3
$2.13M Buy
+38,831
New +$2.8M 0.02% 899
2023
Q2
Sell
-40,582
Closed -$3.07M 2929
2023
Q1
$3.07M Sell
40,582
-35,628
-47% -$2.46M 0.05% 574
2022
Q4
$4.7M Sell
76,210
-6,796
-8% -$361K 0.09% 272
2022
Q3
$3.46M Buy
83,006
+74,584
+886% +$3.24M 0.07% 330
2022
Q2
$265K Buy
+8,422
New +$225K 0.01% 1642

Other funds holding TMDX

Tudor Investment Corp's TMDX Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in Transmedics (TMDX) in Q1 2026: 40,217 shares worth $4M. The stake represents 0.01% of the portfolio and ranks #1315 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in TMDX as recently as Q3 2025.

Tudor Investment Corp first reported a position in TMDX in Q2 2022 and has held it in 12 quarters since. The position peaked at $16.6M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Tudor Investment Corp held 40,217 shares of Transmedics worth $4M as of Q1 2026.
  • Transmedics was a new Tudor Investment Corp position in Q1 2026.
  • Transmedics made up 0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #1315 holding.
  • Tudor Investment Corp first reported a position in Transmedics in Q2 2022 and has held it in 12 quarters since.
  • Tudor Investment Corp's Transmedics position peaked at $16.6M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.